These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31910828)

  • 1. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.
    Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC
    Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study.
    Chung HS; Hwang SY; Kim JA; Roh E; Yoo HJ; Baik SH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM
    Cardiovasc Diabetol; 2022 Jan; 21(1):15. PubMed ID: 35101050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM.
    Yang CP; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Li TC; Lin CC
    Neurology; 2017 Mar; 88(10):944-951. PubMed ID: 28179465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.
    Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC
    Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.
    Lin CC; Yang CP; Li CI; Liu CS; Chen CC; Lin WY; Hwang KL; Yang SY; Li TC
    BMC Med; 2014 Sep; 12():165. PubMed ID: 25255837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between glucose variation and lower extremity amputation incidence in individuals with type 2 diabetes: a nationwide retrospective cohort study.
    Li CI; Cheng HM; Liu CS; Lin CH; Lin WY; Wang MC; Yang SY; Li TC; Lin CC
    Diabetologia; 2020 Jan; 63(1):194-205. PubMed ID: 31686118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risk analysis on visit-to-visit glucose variations and risk of depression: The Taiwan Diabetes Study.
    Li CI; Liu CS; Lin CH; Lin WY; Lee YD; Yang SY; Li TC; Lin CC
    Diabetes Metab; 2020 Jun; 46(3):223-229. PubMed ID: 31472230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
    Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
    Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and shape of the associations of glucose, HbA
    Ruijgrok C; Dekker JM; Beulens JW; Brouwer IA; Coupé VMH; Heymans MW; Sijtsma FPC; Mela DJ; Zock PL; Olthof MR; Alssema M
    Diabetologia; 2018 Jan; 61(1):93-100. PubMed ID: 29018885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
    Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.
    Du TT; Yin P; Zhang JH; Zhang D; Shi W; Yu XF
    Clin Exp Pharmacol Physiol; 2013 Feb; 40(2):63-8. PubMed ID: 23198814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
    Soulimane S; Simon D; Shaw J; Witte D; Zimmet P; Vol S; Borch-Johnsen K; Magliano D; Vistisen D; Balkau B
    Diabetes Res Clin Pract; 2012 Jun; 96(3):392-9. PubMed ID: 21741107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.